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ABSTRACT 
OBJECTIVES: The brain-derived neurotrophic factor (BDNF) is a major participant in 
the regulation of food intake and may play a role in the regulation of the stress response. 
We aimed to investigate whether there is a gene-environment interaction in the 
relationship between stress and BDNF Val66Met polymorphism in relation to dietary 
patterns in a sample of subjects with early psychosis. 
METHODS: We studied 124 early psychotic patients (PD), 36 At-Risk Mental States 
(ARMS) and 62 healthy subjects (HS). Dietary patterns were examined by a dietician. 
Physical activity, life stress and perceived stress were assessed by validated 
questionnaires. BDNF Val66Met polymorphism (rs6265) was genotyped. A gene-
environment interaction was tested with multiple linear regression analysis while 
adjusting for covariates. 
RESULTS: Perceived stress was not associated with calorie intake in HS. In ARMS 
subjects, Met-carriers who presented low-perceived stress were associated with 
increased caloric intake. Conversely, those who presented high-perceived stress were 
associated with reduced caloric intake. In PD, perceived stress was associated with 
increased calorie intake without an effect by BDNF genotype nor a gene-environment 
interaction. Perceived stress was associated with food craving in PD patients, 
independent of genotype, and in ARMS or HS who were Val homozygous. 
CONCLUSIONS: Our study suggests that the common Val66Met polymorphism of the 
BDNF gene may modulate the relationship between life stress and calorie intake in 
subjects at risk for psychosis. 
 
Keywords: Brain-derived neurotrophic factor (BDNF); BDNF Val66Met; early 
psychosis; stress; diet 
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1. Introduction 
 People with schizophrenia have a reduced life expectancy compared to the 
general population (1), which is mainly caused by cardiovascular disease (2). Although 
antipsychotic treatment is one of the main causes of weight gain and metabolic 
abnormalities in psychosis (3), life style factors including unhealthy diet and reduced 
physical activity also play a role (4,5). Life stress is associated with greater calorie 
intake and increased refined sugar consumption in individuals with early psychosis (6). 
This is in accordance with other studies in non-psychiatric populations, which have also 
found that chronic stress is associated with hyperphagia (7,8). 
 Psychosocial stress is implicated in the development of psychotic symptoms (9). 
However, individuals likely differ in their vulnerability to stress. A mechanism that 
could potentially explain between-subject differences is through a gene-environment  
interaction (10). Although life stress has been associated with dietary habits in subjects 
with early psychosis (6), there are no previous studies addressing whether there is a 
gene-environment interaction in the relationship between life stress and eating 
behaviour in early psychotic patients. Genes involved in regulating the adaptive 
behavioural response to stress represent plausible candidates to be explored in studies 
addressing why some individuals are more prone to develop dietary changes and 
metabolic abnormalities. In this sense, the brain-derived neurotrophic factor (BDNF) 
gene (OMIM 113505) is an excellent target because it has been implicated in several 
processes including food intake (11,12) or the regulation of stress responses (13,14). 
Moreover, it is thought to modulate the clinical expression of schizophrenia (15). 
 BDNF is the most profusely expressed neurotrophin in the central nervous 
system and is located predominantly within neurons. It is involved in growth, 
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differentiation, maturation and survival of neurons (16), and contributes to energy 
metabolism, food intake and body weight control by acting as an anorexigenic factor 
(11,12,17). Animal studies have shown reduced hypothalamic expression of BDNF, 
increased hyperphagia and risk of obesity in BDNF-deficient mice (18). Intra‐cranial 
infusion of BDNF into the third ventricle can transiently reverse the eating behaviour 
and obesity. There is a functional single-nucleotide polymorphism (SNP) in the BDNF 
gene, a valine (Val) to methionine (Met) substitution at codon 66 (Val66Met), that has 
an impact on BDNF protein. Met66 allele carriers have been linked with reduced BDNF 
activity-dependent secretion. Although there are no studies exploring the role of this 
polymorphism in the dietary patterns in subjects with psychoses, human studies in other 
clinical populations have reported an increased risk for food restriction (19,20), bulimia 
(20) and restrictive type anorexia nervosa (21) in Met-carriers.  
 Thus the aim of this study was to investigate whether there is a gene-
environment interaction in the relationship between stress and BDNF Val66Met 
polymorphism in relation to dietary patterns in a sample of subjects with early 
psychosis. 
 
2. Materials and methods 
 
2.1. Participants 
 The study sample included 160 individuals who were attending an Early 
Intervention Service for Psychosis (Hospital Universitari Institut Pere Mata, Reus, 
Tarragona, Spain): 1) 124 patients with a psychotic disorder (PD, 82 [66.1%] were first 
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episodes of psychosis) with less than 5 years from the onset of the illness; 2) 36 
individuals with prodromal psychotic symptoms fulfilling the set criteria for At-Risk 
Mental States (ARMS) (22). Recruitment of PD and ARMS individuals was conducted 
by consecutive sampling. We included a control group of healthy subjects (HS, n=62) 
who were recruited by advertisements. All HS were screened to rule out past or current 
histories of psychiatric disorders by direct interviewing by an experienced psychiatrist. 
Exclusion criteria for all participants (HS, ARMS, PD) were: pregnancy, mental 
retardation, severe head injury or neurological disease, active glucocorticoid treatment, 
active substance dependence (other than tobacco or cannabis) and type 1 diabetes 
mellitus. In order to include relatively stable PD patients, clinical assessment was 
performed when subjects had been treated at the program for at least three months. All 
experiments on human subjects were conducted in accordance with the Declaration of 
Helsinki. Ethical approval was obtained from the local ethics committee. After complete 
description of the study to the subjects, written informed consent was obtained. 
 
2.2. Clinical Assessment 
2.2.1. Clinical diagnosis 
All patients were assessed with the Schedules for Clinical Assessment in 
Neuropsychiatry (23). The Operational Criteria Checklist for Psychotic and Affective 
Illness (OPCRIT 4 Windows) was used to generate DSM-IV diagnosis for psychotic 
disorders (schizophreniform disorder [n=22], schizophrenia [n=20], schizoaffective 
disorder [n=12]), and psychotic disorder not otherwise specified [n=70]). ARMS 
subjects were also assessed with the Comprehensive Assessment of At-Risk Mental 
States (CAARMS), to ensure that subjects met criteria for any of the three ultra high 
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risk groups defined by the CAARMS (22): 1) attenuated psychosis (n=28), 2) brief 
limited intermittent psychotic symptoms (n=5), and 3) vulnerability (n=7), that includes 
subjects with a family history of psychosis in first degree relative or  schizotypal 
personality disorder in identified patient with a 30% drop in Global Assessment of 
Functioning (GAF) score from premorbid level, sustained for 1 month. 
2.2.2. Stress measures 
Stressful life events in the previous 6 months were assessed with the Holmes-Rahe 
Social Readjustment Scale (24). This scale was initially developed to explore the 
relationship between social readjustment, stress and susceptibility to illness. It explores 
43 life events and gives a "stress score" for each item, obtaining a final score by adding 
the scores of all present life events. This scale has been validated and used in Spanish 
populations (25). Previous studies include the use of this scale to explore the 
relationship between life events and subclinical psychotic symptoms in the general 
population (26) or metabolic abnormalities in healthy individuals (27). The 14-item 
Perceived Stress Scale (28) was used to explore the psychological repercussion of 
stress. This instrument is a self-report scale that assesses the perception of stressful 
experiences over the previous month. 
  
2.2.3. Dietary assessment and obesity measures 
Dietary patterns were assessed by means of clinical interview conducted by a 
dietician. Food intake was registered by 24 h recall. Dietary recall was applied to all 
participants considering one of the first four working days of the week (from monday to 
thursday) in order to avoid potential changes in dietary habits over the weekend. 
Specialized software (Centre d'Ensenyament Superior de Nutrició i Dietètica, 
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University of Barcelona, Santa Coloma de Gramenet, Barcelona, Spain) was used to 
calculate the daily calorie and nutrient intake. The Food Craving Questionnaire-State 
(FCQ-S) was used to assess craving for foods (29). Cravings have been defined as 
strong desires that, arising from either physiological or psychological underlying states, 
promote drug and food consumption. The FCQ-S covers five domains: 1) an intense 
desire to eat, 2) anticipation of positive reinforcement, 3) anticipation of relief from 
negative states and feelings, 4) preoccupation with food and lack of control over eating, 
5) feelings of hunger. We calculated the full-scale total by adding all item scores. The 
International Physical Activity Questionnaire-short form (IPAQ-SF) (30), was used to 
calculate the level of physical activity in metabolic equivalents (MET-min/week). 
Weight, height, waist circumference and blood pressure were assessed by physical 
examination. Body Mass Index (BMI) was calculated with the formula weight 
(kg)/height (m)
2
.  
2.2.4. Treatments and other clinical information 
Antipsychotic treatment and other socio-demographic and clinical variables were 
requested by semi-structured interview. All patients received second-generation 
antipsychotics. Of all 36 ARMS individuals, 27 (75%) were not receiving antipsychotic 
drugs, 7 (19.4%) were on antipsychotic monotherapy (risperidone [n=1], olanzapine 
[n=3], aripiprazole [n=3]) and 3 were receiving two antipsychotics in combination. Of 
all 124 PD patients, 72 (58.1%) were on antipsychotic monotherapy (risperidone 
[n=31], paliperidone [n=13], olanzapine [n=17], quetiapine [n=1], aripiprazole [n=10]), 
33 (26.6%) were receiving two antipsychotics in combination and 19 (15.3%) were not 
receiving antipsychotic drugs.  
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2.3. DNA extraction and BDNF genotyping 
 Genomic DNA was extracted from peripheral blood mononuclear cells using the 
Gentra Puregene Blood Kit (QIAGEN Iberia S.L., L’Hospitalet de Llobregat, 
Barcelona, Spain) according to the manufacturer’s instructions. The extraction was 
carried out at the Biobank of the Institut d’Investigació Sanitària Pere Virgili (IISPV) 
(Reus, Tarragona, Spain). DNA was genotyped using a TaqMan SNP genotyping assay 
for the rs6265 SNP (assay ID C_11592758_10; Life Technologies, Alcobendas, Madrid, 
Spain). Each 5 µL of PCR reaction mix contained 40 ng of DNA, 2.5 µL of TaqMan 
Universal PCR Master Mix, 0.25 µL of 20X TaqMan SNP Genotyping Assay and 2.25 
µL of DNase-free water. PCR conditions were 10 min at 95°C followed by 40 cycles of 
15 s at 95°C and 1 min at 60°C. The reactions were carried out on an ABI 7900HT Fast 
Real-Time PCR System (Life Technologies, Alcobendas, Madrid, Spain). Five percent 
of samples were run in duplicate for quality control with 100% concordance. 
 
2.4. Statistical analyses 
The Statistical Package for the Social Sciences (SPSS) version 19.0 for Windows 
(IBM Corporation Software Group, Somers, New York, USA) was used for statistical 
analysis.  
2.4.1. Univariate analyses 
T-Student Test or ANOVA was used to compare continuous data between groups. 
Bonferroni adjustment was used for post-hoc comparisons. Chi-square tests were used 
to compare categorical data between groups. Pearson correlations were used to explore 
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the association between continuous variables. Significance was set at p<0.05 (two-
tailed). 
2.4.2. Multivariate analyses 
We conducted a multiple lineal regression analysis to investigate the relationship 
between stress variables and dietary variables (e.g. calorie intake) while controlling for 
potential confounders with a confidence interval of 95%. In this analysis, stress 
measures (e.g. PSS score) and BDNF genes SNP (Met-carriers vs Val/Val 
homozygotes) were used as independent variables. Potential confounders (sex, BMI, 
substance use) were also used as independent variables. Dietary measures were used as 
dependent variables. In order to explore whether there was a gene-environment 
interaction, we tested the interaction between BDNF gene Val66Met SNP and stress 
measures (perceived stress and stressful life events). Those significant interaction terms 
were kept in the final equation. We conducted a multivariate analysis stratified by 
diagnosis (HS vs ARMS vs PD), so three multiple linear regression analyses were 
conducted.  
 
3. Results 
3.1. Clinical differences between groups 
 Socio-demographic and genotype characteristics of samples are described in 
Table 1. Smoking and cannabis use were more prevalent in PD patients when compared 
to ARMS and HS. Conversely, alcohol consumption among patients was low compared 
to HS. We found significant differences in perceived stress (but not in stressful life 
events) between diagnostic groups. Among all groups, the ARMS subjects had greater 
scores in the PSS scale. 
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 Lifestyle variables (dietary habits and physical activity) and obesity measures 
are described in Table 2. ARMS subjects and PD patients reported an increased energy 
intake and reduced protein consumption, when compared to HS. Both ARMS subjects 
and PD patients reported reduced physical activity when compared to HS. Finally, 
individuals with PD had a greater BMI than other groups. 
3.2. Diet and stress measures by diagnostic group and genotype 
 Diet and stress measures by diagnostic group and genotype are presented in 
Table 3. We did not find significant differences in each of these variables between Met-
carriers or Val homozygotes. However, when we explored the relationship between 
stress and lifestyle variables or obesity measures by genotype, we found significant 
differences (Table 4). Perceived stress was associated with a different pattern in calorie 
intake, depending on genotype and diagnostic group: perceived stress was associated 
with a reduced caloric intake in ARMS subjects who were Met-carriers, whereas a 
positive relationship was found in PD patients who were Val homozygous. Perceived 
stress was associated with food craving in PD patients, independent of genotype, and in 
ARMS or HS who were Val homozygous. In HS, perceived stress was also associated 
with increased lipid and fatty acid consumption, reduced protein intake and lower BMI.  
3.3. Multivariate analysis 
We also conducted multiple linear regression analysis that was stratified by 
diagnosis, in order to explore the relationship between perceived stress and calorie 
intake while adjusting for confounders (cannabis and tobacco use, sex and BMI) and 
exploring the gene-environment interaction. In HS, perceived stress was not associated 
with calorie intake (Figure 1a). In ARMS subjects, BDNF genotype (Met-carriers) was 
associated with an increased calorie intake (Standardized β= 1.36, p=0.040). However, a 
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significant negative interaction between perceived stress and Val66Met SNP (Met-
carriers) was found (Standardized β= -1.37, p=0.047). Thus, in ARMS subjects, BDNF 
genotype (Met-carrier in Val66Met SNP) was associated with an increased calorie 
intake, but that in situations of increased perceived stress, Met-carriers reported reduced 
calorie consumption (Figure 1b). On the other hand, in PD patients, perceived stress 
was associated with an increased calorie intake (Standardized β= 0.217, p= 0.021), 
without an effect by genotype or a gene-environment interaction (Figure 1c). We did not 
find an interaction between stressful life events and genotype. 
 
4. Discussion 
 In this cross-sectional study exploring the relationship between stress and 
dietary habits in three diagnostic groups (HS, ARMS subjects and PD patients) in 
relation to a SNP of the BDNF gene (Val66Met), we found a gene-environment 
interaction in ARMS subjects only. While in both HS and PD patients this genetic 
polymorphism did not seem to affect the relationship between stress and energy intake, 
in ARMS subjects carriers of the Met-allele, a negative relationship between stress and 
diet was found (a lower calorie intake was reported by those subjects with increased 
perceived stress).  
 These findings are in accordance with previous genetic studies that have linked 
eating disorders, particularly restrictive type anorexia nervosa, with Val66Met Met-
allele carriers (21). Other studies in healthy populations have also found a restricted 
energy intake in Met-carriers adolescents with maladaptive or problematic eating 
attitudes and behaviours (19), or adolescent girls with food restrictive behaviours (20). 
Although BDNF plays an essential role in neuronal survival and differentiation, as well 
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as neuronal plasticity, it is also an anorexigenic factor involved in the regulation of food 
intake (12,17). Interestingly, in animal models using BDNF knock-out heterozygous 
mice with only one functional BDNF allele, a reduction of BDNF expression in the 
hypothalamus has been demonstrated with associated hyperphagia and obesity (18,31).  
 Of all diagnostic groups, we only found a gene-environment effect in the ARMS 
group. ARMS subjects showed increased perceived stress, which fits well with other 
studies in the literature reporting similar findings (32). The existing clinical differences 
between ARMS and PD groups, or a different stage of the illness (prodromal vs 
established psychosis), may explain a distinct pattern in the relationship between BDNF 
gene and perceived stress, in relation to dietary habits. In a previous study by our group 
(6) we also found a different pattern by diagnosis in the relationship between intake of 
‘comfort foods’ and stressful life ev nts: In PD subjects, life stress was associated with 
increased intake of refined sugar, whereas in ARMS and HS subjects it was related to a 
decreased intake of refined sugar. In our current study we have also included 
information on craving for foods. Food craving refers to an intense desire or urge to eat 
specific foods of which chocolate is the most often craved one among other highly 
palatable foods (33). In line with our previous study (6), ARMS individuals that are 
Met-allele carriers of the BDNF Val66Met polymorphism also report lower craving for 
foods (with similar FCQ-S scores as HS), when compared to PD patients that are Met-
allele carriers. The mechanistic pathways leading to a distinct relationship between 
perceived stress, calorie intake and BDNF genotype in ARMS and PD groups are 
uncertain. We wonder whether distinct patterns may reflect different levels of 
cumulative stress and adaptation. The brain controls and coordinates behavioural and 
physiological adjustments to meet the demands imposed by stressors (34). The active 
process of responding to a challenge to the body by triggering chemical mediators of 
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adaptation (hypothalamic-pituitary-adrenal, autonomic, metabolic, immune) can be 
adaptive in the short term (allostasis) and maladaptive in the long term (allostatic load). 
Lifestyle behaviour is another important aspect of individual response to stress in 
relation to allostasis and allostatic load. Although speculative, ARMS individuals may 
have a lower allostatic load than patients with a PD, because it may be hypothesized 
that disease has emerged in this latter group as a failure to adapt to stress. In line with 
this, acute and chronic stress have different effects on appetite, as acute stress is 
associated with anorexia and chronic stress with hyperphagia (35). In acute stress, CRH 
stimulates POMC neurons of the arcuate nucleus which elicit anorexic signals, via a-
MSH release, and suppress neuropeptide Y, a potent orexigen. In turn, chronic stress 
and the increase of circulating glucocorticoid concentration eventually promote the 
intake of carbohydrates and fat and decrease energy expenditure by suppressing CRH 
and stimulating NPY hypothalamic secretion. The different pattern in ARMS and PD in 
those individuals with a genetic vulnerability to stress (e.g. Met-allele carriers of the 
BDNF Val66Met polymorphism), could be explained by a lower allostatic load and 
maintenance of adaptative responses in ARMS individuals (that would mimic acute 
effect responses on appetite with reduced calorie intake by stress) and an increased 
allostatic load and lack of adaptation to chronic stress in PD subjects (leading to 
increased calorie intake by stress in this group).  
 Another potential explanation of the differences between ARMS and PD groups 
in the relationship between stress and energy intake is that PD patients were receiving 
more antipsychotic treatment. It is plausible that the effect of perceived stress on dietary 
habits may be modified by antipsychotic treatment, which interacts with the 
dopaminergic and serotoninergic systems (33), that are also involved in the control of 
eating behaviour. Thus, a potential gene-environment interaction in PD subjects may be 
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obscured by treatment with antipsychotic drugs in this subgroup. Cannabis use is 
another factor that may partially explain some of the differences in the results between 
ARMS and PD groups, because PD patients reported more daily cannabis consumption. 
Cannabinoids promote energy intake by their action at specific brain regions that are 
important in the control of eating motivation (37). 
 Several limitations must be acknowledged. The cross-sectional design of the 
study does not allow inferring causality in the relationship between life stress and 
dietary habits. Some variables were retrospectively assessed with questionnaires (24), 
which may induce a recall bias. BDNF-serotonin transporter gene-gene interactions 
were not controlled. BDNF and serotonin systems interact with each other to regulate 
the development and plasticity of neural circuits (35). It is plausible that environmental 
exposures could trigger the expression of a gene that in turn modifies other genes. 
Future studies may address whether the effects of BDNF Val66Met polymorphism 
interact with other genes such as the serotonin transporter gene. Finally the sample size 
was relatively small, in particular for the ARMS group, thus some negative findings 
could be influenced by a lack of statistical power. Small samples also increase the rates 
of false-positive results due to a type I error. For this reason, it is important to replicate 
our findings with larger samples.  
 On the other hand, our study has several strengths among which it should be 
emphasized that is the first study of the gene-environment interaction in ARMS subjects 
and PD patients exploring how BDNF polymorphism (Val66Met) affects the diet in 
correlation with stress life events, adding important information to our previous study 
that assessed dietary habits and stress measures in ARMS subjects and PD patients 
groups without considering genetic implications (6). Besides, a detailed and thorough 
dietary assessment was conducted by a dietician, who administrated a semi structured 
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interview and registered calorie intake with a special software and a control group of 
healthy volunteers was included. 
 Further longitudinal studies are required to describe temporal changes in eating 
behaviour, before or after the diagnosis of schizophrenia or other PD, in order to 
elucidate whether these changes are linked to the illness of may be considered a 
consequence of psychopharmacological treatment. Future studies addressing this topic 
need to consider controlling for multi-genic interactions and measuring BDNF levels. 
This is important in the design of future preventive interventions that may target 
improvement of dietary habits and strategies to cope with stress in subjects with early 
psychosis, particularly in subjects at high risk for psychosis. 
 A deeper study on this topic and future advances in the understanding of the 
complex interaction between gene, environment and nutrition may help to find new 
ways to prevent this illness and lower the costs, raising the quality of life. Our study 
suggests that the BDNF is a candidate gene that may help to identify vulnerable people 
with stress-related dietary habits in the field of early psychosis, and highlights the need 
to continue exploring the potential role of neurotrophins in the interplay between stress 
and diet in individuals who are at risk for psychosis. 
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Figure 1. Scatter plot of the relationship between perceived stress and calorie intake in 
healthy subjects (1a), at-risk mental states (1b) and patients with a psychotic disorder 
(1c). Regression lines for each Val66Met genotype group (Val/Val vs Met-carriers) are 
presented. A gene-environment effect was observed in ARMS individuals (1b). 
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Table 1.  Clinical, stress and genetic variables of the sample. 
 
 
 
 
 
Healthy Subjects 
N=62 
ARMS 
N=36 
Psychotic 
Disorder 
N=124 
P value 
Age 23.5 (3.5) 22.2 (4.6) 24.7 (4.9) 0.098 
Sex      
Male 32 (51.6) 26 (72.2) 81 (65.3) 0.082 
Female  30 (48.4) 
 
10 (27.8) 
 
43 (34.7) 
 
 
Ethnic Group  
 
 
 
 
 
 
Caucasian 59 (95.2) 
 
32 (88.9) 
 
95 (76.6) 
 
0.204 
Black 0 (0) 0 (0) 1 (0.8)  
Gipsy 0 (0) 0 (0) 5 (4.0)  
Asian 0 (0) 
 
0 (0) 
 
1 (0.8) 
 
 
Arabian 1 (1.6) 
 
1 (2.8) 
 
10 (8.1) 
 
 
Latinoamerican  2 (3.2) 
 
3 (8.3) 
 
12 (9.7) 
 
 
Civil Status     
Single 43 (69.4) 
 
29 (80.6) 
 
99 (79.8) 
 
0.207 
Lives with couple/ Married 19 (30.6) 
 
6 (16.7) 
 
22 (17.7) 
 
 
Divorced 0 1 (2.8) 3 (2.4)  
Work Status     
Employed/ Student 55 (88.7) 
 
24 (66.7) 
 
44 (35,5) 
 
<0.001 
Unemployed 7 (11.3) 12 (33.3) 80 (64.5)  
Drug Use     
Tobacco      
No 41 (66.1) 20 (55.6) 33 (26.6) <0.001 
Occasionally 5 (8.1) 1 (2.8) 4 (3.2)  
Daily 16 (25.8) 15 (41.7) 87 (70.2)  
Cannabis     
No 49 (79.0) 26 (72.2) 70 (56.5) <0.001 
Occasionally 11 (17.7) 5 (13.9) 12 (9.7)  
Daily 2 (3.2) 5 (13.9) 42 (33.9)  
Alcohol     
No 5 (8.1) 12 (33.3) 41 (33.1) <0.001 
Occasionally 56 (90.3) 23 (63.9) 66 (53.2)  
Daily 1 (1.6) 1 (2.8) 17 (13.7)  
Stress measures     
PSS 18.7 (7.4) 32.5 (11.0) 24.8 (9.0) <0.001a,b,c 
SLE (Holmes-Rahe score) 107.1 (96.7) 150.5 (83.9) 158.1 (118.0) 0.052 
BDNF (rs6262) genotype     
Val/Val 34 (54.8) 20 (55.5) 72 (58.0) 0.908 
Val/Met 25 (40.3) 14 (38.9) 43 (34.7)  
Met/Met 3 (4.8) 
 
2 (5.5) 
 
9 (7.3) 
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Data are mean (SD) or N (%). 
Significant ANOVA post-hoc comparisons (after a Bonferroni adjustment) are highlighted: 
a 
HS vs ARMS; 
b
HS 
vs PD; 
c
ARMS vs PD 
Abbreviation: ARMS= At-Risk Mental State; PSS= Perceived Stress Scale; SLE= Stressful life events; Val= 
Valine; Met= Methionine. 
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2. Lifestyle variables and obesity measures among diagnostic groups. 
 
Data are mean (SD) or N (%). 
Significant ANOVA post-hoc comparisons (after a Bonferroni adjustment) are highlighted: 
a 
HS vs ARMS; 
b
HS vs PD; 
cARMS vs PD 
Abbreviation: ARMS= At-Risk Mental State; IPAQ= International Physical Activity Questionnaire; FCQ-S= Food Craving 
Questionnaire-State; IPAQ= International Physical Activity Questionnaire; MET: Metabolic Equivalent of Task; BMI= 
Body mass index. 
 
Healthy Subjects 
N=62 
ARMS 
N=36 
Psychotic Disorder 
N=124 
P value 
Dietary Intake (24h recall):     
Total energy (Kcal) 1741.6 (424.3) 2424.1 (863.0) 2509.4 (653.3) <0.001a,b 
Lipids (%) 35.9 (6.0) 36.6 (10.3) 37.6 (6.8) 0.318 
Proteins (%) 20.3 (4.9) 15.6 (4.5) 16.11 (3.5) <0.001
a,b
 
Carbohydrates (%) 43.4 (6.3) 46.4 (11.4) 45.7 (8.0) 0.121 
Saturated fatty acids (%) 10.9 (2.9) 13.1 (5.1) 12.5 (3.3) 0.003 
Refined sugar (%) 18.4 (6.4) 21.1 (11.9) 20.1 (6.6) 0.197 
Food craving (FCQ-S) 28.3 (10.5) 32.0 (12.7) 33.6 (14.3) 0.038 
Physical activity (IPAQ)     
MET-min/week 2954.7 (2227.3) 1289.5 (1144.1) 1672.5 (1370.3) <0.001a,b 
Obesity measures     
BMI (kg/m
2
) 22.2 (3.8) 22.2 (3.5) 24.3 (4.6) 0.002b,c 
Weight classification by BMI     
Underweight (<18.5 kg/m
2
) 5 (8.2) 4 (11.1) 5 (4.1) 0.012 
Normal (18.5-24.9 kg/m
2
) 46 (75.4) 22 (61.1) 77 (62.6)  
Overweight (25-29.9 kg/m
2
) 7 (11.5) 10 (27.8) 28 (22.8)  
Obesity(≥30 kg/m
2
) 3 (4.9) 0 13 (10.6)  
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Table 3. Diet and stress measures. Stratified analysis by diagnosis and BDNF Val66Met polymorphism. 
 
Healthy Subjects 
N=62 
ARMS 
N=36 
Psychotic Disorder 
N=124 
Val/Val 
N=34 
Met Carriers 
N=28 
Val/Val 
N=20 
Met Carriers 
N=16 
Val/Val 
N=72 
Met Carriers 
N=52 
Dietary intake 
(24h recall) 
      
Total energy (Kcal) 1762.5 
(468.4) 
1716.3 
(370.7) 
2329.5 
(904.1) 
2542.4 
(821.9) 
2476.7 
(626.5) 
2554.8 
(692.3) 
Lipids (%) 36.2 (6.1) 35.5 (5.9) 36.7 (10.9) 36.4 (10.0) 36.8 (6.3) 38.7 (7.3) 
Proteins (%) 19.2 (5.2) 21.6 (4.2) 15.5 (4.6) 15.8 (4.5) 15.9 (3.7) 16.4 (3.2) 
Carbohydrates (%) 43.9 (7.1) 42.7 (5.1) 46.3 (12.1) 46.6 (10.9) 46.8 (8.1) 44.2 (7.7) 
Saturated fatty acids (%) 11.1 (2.8) 10.6 (2.9) 12.8 (4.3) 13.4 (6.1) 12.8 (3.5) 11.9 (2.8) 
Refined sugar (%) 19.1 (6.3) 17.6 (6.3) 20.0 (13.2) 22.5 (10.3) 20.8 (6.8) 19.0 (6.3) 
Food craving (FCQ-S) 27.7 (9.6) 29.1 (11.6) 34.5 (13.6) 28.9 (11.2) 34.3 (14.7) 32.6 (13.9) 
Stress measures       
PSS 19.3 (8.0) 18.0 (6.6) 32.4 (13.0) 32.7 (8.6) 25.2 (8.7) 24.2 (9.3) 
SLE (Holmes-Rahe score) 112.7 (106.9) 100.3 (84.5) 172.0 (90.2) 124.9 (70.0) 176.5 (124.6) 133.3 (104.8) 
 
Abbreviation: Val/Val= homozygous for valine at codon 66; ARMS= At-Risk Mental State; PSS= Perceived Stress Scale; SLE= 
Stressful life events; FCQ-S= Food Craving Questionnaire-State. 
 
Data are mean (SD)= Standard Deviation 
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Table 4. Correlations between lifestyle variables and stress measures. Stratified analysis by diagnosis and BDNF Val66Met polymorphism. 
    
 
 
Healthy Subjects 
N=62 
ARMS 
N=36 
Psychotic Disorder 
N=124 
Val Homozygous 
N=34 
Met Carriers 
N=28 
Val Homozygous 
N=20 
Met Carriers 
N=16 
Val Homozygous 
N=72 
Met Carriers 
N=52 
SLE (HR) PSS SLE (HR) PSS SLE (HR) PSS SLE (HR) PSS SLE (HR) PSS SLE (HR) PSS 
Dietary intake 
(24h recall) 
            
Total energy (Kcal) -0.257 
 
0.018 
 
0.050 
 
0.081 
 
0.059 
 
0.119 
 
-0.303 
 
-0.594* 
(0.015) 
0.137 
 
0.262* 
(0.033) 
0.255 
 
0.242 
 
Lipids (%) 0.126 
 
0.048 
 
-0.029 
 
0.558* 
(0.004) 
0.151 
 
-0.294 
 
-0.362 
 
-0.404 
 
-0.142 
 
-0.019 
 
-0.056 
 
-0.083 
 
Proteins (%) -0.118 
 
-0.254 
 
0.083 
 
-0.444* 
(0.026) 
-0.287 
 
-0.408 
 
0.203 
 
0.168 
 
-0.046 
 
-0.228 
 
-0.394* 
(0.007) 
-0.255 
 
Carbohydrates (%) -0.079 
 
0.072 
 
0.060 
 
-0.260 
 
0.128 
 
0.332 
 
0.206 
 
0.193 
 
0.140 
 
0.176 
 
0.245 
 
0.198 
 
Saturated fatty acids (%) -0.100 
 
0.119 
 
-0.247 
 
0.444* 
(0.026) 
0.182 
 
-0.235 
 
-0.156 
 
-0.187 
 
-0.084 
 
0.059 
 
0.012 
 
0.016 
 
Refined sugar (%) -0.216 
 
-0.186 
 
-0.252 
 
-0.308 
 
-0.144 
 
0.151 
 
0.132 
 
0.127 
 
0.189 
 
0.107 
 
0.230 
 
0.281 
 
Food craving 
(FCQ-S) 
0.366* 
(0.047) 
0.489* 
(0.005) 
0.114 
 
0.196 
 
0.252 
 
0.546* 
(0.016) 
0.192 
 
0.380 
 
0.112 
 
0.327* 
(0.008) 
0.464* 
(0.001) 
0.430* 
(0.003) 
Physical Activity 
(IPAQ) 
0.192 
 
0.148 
 
0.174 
 
0.206 
 
0.225 
 
-0.343 
 
0.413 
 
-0.005 
 
0.135 
 
-0.365* 
(0.003) 
-0.215 
 
-0.115 
 
BMI 0.175 
 
0.237 
 
-0.011 
 
-0.457* 
(0.032) 
-0.006 
 
0.340 
 
0.094 
 
-0.341 
 
-0.104 
 
-0.079 
 
-0.021 
 
-0.086 
 
 
*Significant P values are shown. 
Abbreviation: ARMS= At-Risk Mental State; SLE (HR)= Stressful life events (Homes-Rahe score); PSS= Perceived Stress Scale; IPAQ= International Physical Activity Questionnaire; FCQ-
S= Food Craving Questionnaire-State; BMI= Body mass index. 
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Figure 1. Scatter plot of the relationship between perceived stress and calorie intake in healthy subjects 
(1a), at-risk mental states (1b) and patients with a psychotic disorder (1c). Regression lines for each 
Val66Met genotype group (Val/Val vs Met-carriers) are presented. A gene-environment effect was observed 
in ARMS individuals (1b).  
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